(VIANEWS) – MainStreet Bancshares (MNSB), Inter Parfums (IPAR), Zynex (ZYXI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MainStreet Bancshares (MNSB)
27.7% sales growth and 14.93% return on equity
MainStreet Bancshares, Inc. operates as the bank holding company for MainStreet Bank that provides various banking products and services for individuals, small to medium-sized businesses, and professional service organizations primarily in Northern Virginia and the greater Washington, the District of Columbia metropolitan area. The company offers demand, NOW, money market, savings, and sweep accounts, as well as certificates of deposit; business and consumer checking, interest-bearing checking, business account analysis, and other depository services; and cash management, wire transfer, check imaging, remote deposit capture, and courier services. It also provides commercial loans, including government contract receivables, plant and equipment, general working capital, contract administration, and acquisition loans; commercial real estate, real estate construction, and residential real estate loans; and consumer loans comprising car loans, term loans, credit cards, and overdraft protection. In addition, the company provides payment service and deposit insurance solutions; remote deposit of checks; and internet bill payment, online cash management, and online and mobile banking services. It operates through a network of seven branches located in Herndon, Fairfax, Fairfax City, McLean, Clarendon, and Leesburg, Virginia, and one branch in Washington, the District of Columbia; and provides automated teller machine transaction services at approximately 55,000 locations in the United States, Canada, the United Kingdom, and Mexico. MainStreet Bancshares, Inc. was incorporated in 2003 and is headquartered in Fairfax, Virginia.
Earnings Per Share
As for profitability, MainStreet Bancshares has a trailing twelve months EPS of $3.63.
PE Ratio
MainStreet Bancshares has a trailing twelve months price to earnings ratio of 6.37. Meaning, the purchaser of the share is investing $6.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.93%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 21.1% and a drop 20.6% for the next.
Yearly Top and Bottom Value
MainStreet Bancshares’s stock is valued at $23.12 at 01:22 EST, way below its 52-week high of $30.98 and way higher than its 52-week low of $19.43.
2. Inter Parfums (IPAR)
21.1% sales growth and 21.85% return on equity
Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. The company operates in two segments, European Based Operations and United States Based Operations. It offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade New York, Lanvin, Montblanc, Paul Smith, Repetto, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, bebe, Dunhill, Hollister, French Connection, Graff, GUESS, Lily Aldridge, MCM, Bella Vita, and Oscar de la Renta brand names, as well as under the Intimate and Aziza names. It sells its products to department stores, specialty stores, duty free shops, beauty retailers, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Inter Parfums has a trailing twelve months EPS of $4.37.
PE Ratio
Inter Parfums has a trailing twelve months price to earnings ratio of 31.19. Meaning, the purchaser of the share is investing $31.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.85%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 5.8% and a negative 3.1%, respectively.
Volume
Today’s last reported volume for Inter Parfums is 112845 which is 19.63% below its average volume of 140407.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Inter Parfums’s EBITDA is 3.79.
3. Zynex (ZYXI)
17.9% sales growth and 24.58% return on equity
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Earnings Per Share
As for profitability, Zynex has a trailing twelve months EPS of $0.46.
PE Ratio
Zynex has a trailing twelve months price to earnings ratio of 20.57. Meaning, the purchaser of the share is investing $20.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.58%.
4. The Simply Good Foods Company (SMPL)
16.5% sales growth and 9.02% return on equity
The Simply Good Foods Company operates as a consumer packaged food and beverage company in North America and internationally. The company develops, markets, and sells snacks and meal replacements. It offers primarily nutrition bars, ready-to-drink (RTD) shakes, sweet and salty snacks, protein bars, cookies, pizza, protein chips, recipes, and confectionery products, as well as licensed frozen meals under the Atkins, Atkins Endulge, and Quest brand names. The company distributes its products to various retail channels, such as mass merchandise, grocery and drug channels, club stores, convenience stores, gas stations, and other channels. It also sells its products through e-commerce channels, including atkins.com, questnutrition.com, and amazon.com. The Simply Good Foods Company is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, The Simply Good Foods Company has a trailing twelve months EPS of $1.27.
PE Ratio
The Simply Good Foods Company has a trailing twelve months price to earnings ratio of 28.23. Meaning, the purchaser of the share is investing $28.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.02%.
Sales Growth
The Simply Good Foods Company’s sales growth is 2.3% for the present quarter and 16.5% for the next.
Yearly Top and Bottom Value
The Simply Good Foods Company’s stock is valued at $35.85 at 01:22 EST, way under its 52-week high of $41.91 and way above its 52-week low of $29.21.
